Particle Therapy Market Share & Size Forecast, 2024 - 2032

Particle Therapy Market - By Type (Proton, Heavy Ion), By Product (Synchrotrons, Cyclotrons), By Services, By System (Multi-Room Systems, Single-Room Systems), By Cancer Type (Pediatric Cancer, Lung Cancer, Bladder, Breast Cancer) & Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data Sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Particle therapy industry 360&ordm; synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Type trends

2.1.4&nbsp;&nbsp;&nbsp; Product &amp; services trends

2.1.5&nbsp;&nbsp;&nbsp; System trends

2.1.6&nbsp;&nbsp;&nbsp; Cancer type trends

Chapter 3&nbsp;&nbsp;&nbsp;Particle Therapy Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing global burden of cancer

3.2.1.2&nbsp;&nbsp;&nbsp;Advantages offered by particle therapy

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing number of particle therapy centers worldwide

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Infrastructural challenges in healthcare facilities

3.2.2.2&nbsp;&nbsp;&nbsp;Unfavorable reimbursement policies and limited insurance coverage

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By type

3.3.2&nbsp;&nbsp;&nbsp; By product &amp; services

3.3.3&nbsp;&nbsp;&nbsp; By system

3.3.4&nbsp;&nbsp;&nbsp; By cancer type

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Particle Therapy Market, By Type, 2018 - 2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by type

5.2&nbsp;&nbsp;&nbsp; Proton therapy

5.3&nbsp;&nbsp;&nbsp; Heavy ion therapy

Chapter 6&nbsp;&nbsp;&nbsp;Particle Therapy Market, By Product &amp; Services, 2018 - 2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by product &amp; services

6.2&nbsp;&nbsp;&nbsp; Product

6.2.1&nbsp;&nbsp;&nbsp; Synchrotrons

6.2.2&nbsp;&nbsp;&nbsp; Cyclotrons

6.2.3&nbsp;&nbsp;&nbsp; Synchrocyclotrons

6.3&nbsp;&nbsp;&nbsp; Services

Chapter 7&nbsp;&nbsp;&nbsp;Particle Therapy Market, By System, 2018 - 2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by system

7.2&nbsp;&nbsp;&nbsp; Multi-room systems

7.3&nbsp;&nbsp;&nbsp; Single-room systems

Chapter 8&nbsp;&nbsp;&nbsp;Particle Therapy Market, By Cancer Type, 2018 - 2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by cancer type

8.2&nbsp;&nbsp;&nbsp; Pediatric cancer

8.3&nbsp;&nbsp;&nbsp; Lung cancer

8.4&nbsp;&nbsp;&nbsp; Bladder cancer

8.5&nbsp;&nbsp;&nbsp; Brain &amp; spinal cord cancer

8.6&nbsp;&nbsp;&nbsp; Head &amp; neck cancer

8.7&nbsp;&nbsp;&nbsp; Breast cancer

8.8&nbsp;&nbsp;&nbsp; Gastrointestinal cancer

8.9&nbsp;&nbsp;&nbsp; Other cancers

Chapter 9&nbsp;&nbsp;&nbsp;Particle Therapy Market, By Region, 2018 - 2032 (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by region

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; Japan

9.4.2&nbsp;&nbsp;&nbsp; China

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Danfysik A/S

10.2&nbsp;&nbsp;&nbsp; Hitachi, Ltd.

10.3&nbsp;&nbsp;&nbsp; IBA

10.4&nbsp;&nbsp;&nbsp; Mevion Medical Systems

10.5&nbsp;&nbsp;&nbsp; Optivus Proton Therapy, Inc.

10.6&nbsp;&nbsp;&nbsp; ProTom International

10.7&nbsp;&nbsp;&nbsp; Provision Healthcare

10.8&nbsp;&nbsp;&nbsp; Sumitomo Heavy Industries, Ltd.

10.9&nbsp;&nbsp;&nbsp; Siemens Healthcare GmbH

10.10&nbsp;&nbsp;&nbsp; Advanced Oncotherapy Plc. 
&nbsp;

Particle Therapy Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters